Arrowstreet Capital Limited Partnership Has $125.10 Million Stock Holdings in Agilent Technologies, Inc. $A

Arrowstreet Capital Limited Partnership boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 116.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 919,383 shares of the medical research company’s stock after purchasing an additional 494,006 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Agilent Technologies were worth $125,100,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its stake in shares of Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after acquiring an additional 270 shares during the last quarter. Jones Financial Companies Lllp raised its position in Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after purchasing an additional 769 shares during the last quarter. Geneos Wealth Management Inc. raised its position in Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after purchasing an additional 212 shares during the last quarter. Acadian Asset Management LLC raised its position in Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after purchasing an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC bought a new position in Agilent Technologies in the 2nd quarter worth approximately $273,000.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Piper Sandler assumed coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price objective for the company. HSBC dropped their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Morgan Stanley dropped their target price on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Finally, UBS Group dropped their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and an average target price of $160.93.

Agilent Technologies Price Performance

Shares of NYSE A opened at $130.52 on Tuesday. The stock has a market capitalization of $36.86 billion, a price-to-earnings ratio of 26.21, a PEG ratio of 2.31 and a beta of 1.26. The business has a 50-day moving average of $120.55 and a 200-day moving average of $127.49. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.84 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter last year, the company earned $1.31 EPS. Agilent Technologies’s revenue for the quarter was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 6 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.